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Cancer is one of the diseases with most deaths worldwide, around 8.2 million annually. For this reason, several treatments and
diagnostic tools have been investigated and developed over the past decades. Among them, a dual-image systemhas been developed
to achieve and enhance the detection of cancer, which has not been done with systems currently available. The present study
describes the preparation of a dual-image targeting system composed of magnetic iron oxide nanoparticles functionalized with
folic acid and rhodamine; nanoparticles synthesis was achieved by a coprecipitation method; the functionalization was carried out
by a carbodiimide with folic acid and/or the rhodamine isothiocyanate; conjugates were characterized by spectrometric techniques;
toxicity was measured by cell proliferation assay on HeLa cells using progressive concentrations of functionalized nanoparticles.
Cellular uptake assay was carried out by competitive assay on HeLa cells. Iron oxide magnetite nanoparticles, modified with folic
acid and rhodamine, were successfully synthetized with a particle size lower than 20 nm (TEM), EDS, HRTEM, and XDR showed
highly crystalline Fe3O4 nanoparticles. Folic acid and rhodamine were conjugated with high efficiency. A significant selectivity
and uptake, facilitated by surface modification of iron oxide nanoparticles with folic acid, were demonstrated. The multifunctional
system showed suitable physicochemical and biological properties for cell targeting through folate receptors.
1. Introduction
Molecular imaging comprises the noninvasive monitoring of
functional and spatiotemporal processes at cellular, subcellu-
lar, or molecular levels in humans and other living systems.
Although molecular imaging has existed for decades, recent
advances in molecular and cell biology, imaging technology,
and material sciences have greatly increased its power and
potential as specific and sensitive medical tools [1].
Nanoparticles (NPs) are submicronmoieties with diame-
ters ranging from 1 to 100 nm, depending on their intended
purpose, which have many novel physical and chemical
properties that are not present in the atom nor the bulk
counterpart, related to the dimensions and shape, as well as
morphology [2, 3]; NPs have been used in many different
biological and medical applications as key components for
imaging probe design [4–7].
Iron oxide nanoparticles (IONPs) of magnetite type
(Fe3O4) have desirable physical and biochemical character-
istics (e.g., superparamagnetism, high coercivity, low Curie
temperature (𝑇𝐶), high magnetic susceptibility, chemical
stability in physiological conditions, high saturation fields,
Hindawi
Journal of Nanomaterials
Volume 2017, Article ID 5184167, 11 pages
https://doi.org/10.1155/2017/5184167
2 Journal of Nanomaterials
biocompatibility, and biodegradable and nontoxic nature),
which make them useful in the diagnosis and treatment in
the oncology field [8–10].
A desirable molecular imaging probe must be able to
reach specific targets with high affinity, sensitivity, and suit-
able biodistribution properties. Nanoparticle-based molecu-
lar imaging probes can be functionalized or modified due
to their high surface area-to-volume ratio, by bioactive
molecules, typically through chemical coupling via amide
or ester bonds in order to reach a target site. Some of the
molecules used as targeting elements include small ligands,
antibodies and derivatives, aptamers and other nucleic acids,
polyunsaturated fatty acids, peptides, and proteins [2, 11–13].
Furthermore, surface modification can include fluorescence
dyes, genes, or drugs, to provide multimodal functionalities
[3].
Folic acid (FA) is a water-soluble vitamin, can be easily
conjugated to supramolecular and macromolecular struc-
tures, and has been used as a vector for cancer cells targeting
due to its high affinity (𝐾𝑑 ∼ 10
−10mM) for its corresponding
folate receptors (FRs: FR𝛼, FR𝛽, and FR𝛾), to mediate cellular
uptake of FA [12, 14–18].
FRs are overexpressed in a large number of cancer cells
and are positively associated with tumor stage and histologic
grade (e.g., ovarian cancer, endometrial cancer, kidney can-
cer, colorectal cancer, lung cancer, breast cancer, brain cancer,
and myeloid leukemia); FRs provide a special marker that
distinguishes cancer cells from normal cells, as these exhibit
limited expression, are largely restricted to those important
for embryonic development (e.g., placenta and neural tubes),
and present low levels in folate resorption through kidney
and lung. It has been reported that folate conjugation to the
IONPs enhances the cellular uptake to target cells, improving
therapeutic efficacy [12, 17–21].
Rhodamine B isothiocyanate, on the other hand, is a
fluorophore that belongs to the xanthene dyes family. Due to
its photophysical properties and excellent photostability, it is
used as fluorescence probes for imaging sensor techniques.
Optical imaging allows noninvasive drug visualization in
cells and tissues in order to understand molecular processes
in real time. Specifically, it has been reported that several
MNPs (magnetic nanoparticles) can be used as dual-modality
imaging probes, in nuclear and optical fluorescence imaging
which is the case of IONPs [22–25].
Therefore, we aimed to develop a tumor-targeting dual-
image system based on IONPs with folic acid as a vector
and rhodamine isothiocyanate as an imaging agent, primarily
designed for noninvasive monitoring, in order to acquire
high-quality targeted images without cytotoxicity to normal
cells.
2. Materials and Method
All chemicals were of analytical grade from commer-
cial sources used without further purification. Ferric chloride
hexahydrate (FeCl3⋅6H2O), ferrous chloride tetrahydrate
(FeCl2⋅4H2O), folic acid, N-(3-dimethylaminopropyl)-𝑁󸀠-
ethylcarbodiimide hydrochloride (EDC), 4-(dimethylam-
ino)pyridine (DMAP), 2-aminoethylphosphonic acid (2-
AEP), and rhodamine B isothiocyanate mixed isomers
(RITC) were purchased from Sigma-Aldrich Chemical Co.
(St. Louis, MO, USA). Folate-free RPMI-1640 medium,
bovine fetal serum, NaHCO3, antibiotic-antimycotic solu-
tion (100x) containing penicillin, streptomycin, and ampho-
tericin, and other chemicals and solvents were of reagent
grade. The HeLa cell line was obtained from the National
Institute of Cancerology, Mexico.
2.1. Synthesis of Magnetic Iron Oxide Nanoparticles (IONPs)
and Surface Activation. Bare magnetic iron oxide nanoparti-
cles were synthesized by an alkaline coprecipitation of Fe3+
and Fe2+, in agreement with Banerji et al., [26]. For surface
activation, a freshly prepared aqueous solution of 2-AEP
(1mM) was added to 4mM of a colloidal suspension of
NPs with sonication using a high-intensity ultrasonic probe
during an hour. Then, the resulting nanoparticle suspension
was stirred vigorously at 25∘C for 24 h. The particles were
then washed with deionized water three times via magnetic
decantation and finally dried by evaporation at 37∘C. Samples
were stored for posterior use (see Figure 1(a)).
2.2. Synthesis of the Iron Oxide Folate Conjugate (IONPs-FA).
Magnetic iron oxide NPs were modified with folic acid (FA)
using a solution of FA (2.5mM) in 5mL of dichloromethane
(DCM).The solution wasmixed with an ethanolic solution of
N-(3-dimethylaminopropyl)-𝑁󸀠-ethylcarbodiimide (EDC)
(75mM) and 4-(dimethylamino) pyridine (DMAP) (15mM).
Afterwards, the solution was sonicated using a high-intensity
ultrasound probe during 2 h. The solution was allowed
to stand overnight. Posteriorly, the solution was stirred
vigorously at 25∘C during 24 h, and the IONPs were
recovered and washed via magnetic decantation, using
ethanol and deionized water as diluents (see Figure 1(b)).The
product was stored for use in the subsequent steps.
2.3. Synthesis of Amine-Functionalized Magnetofluorescent
RITC Nanoparticles (IONPs-RITC). An aqueous suspension
of 2-AEP-functionalized INOPs (∼25mg) was prepared and
homogenized using a high-intensity ultrasound probe for
10min. Then, RITC (0.25mM) was dissolved in 10mL of
DMSO, and the solution of RITC was added dropwise to
the aqueous suspension. Once the mixture was complete, the
resulting suspension was sonicated for an hour in the dark.
Nanoparticles were recovered by magnetic concentration
and washed thoroughly with deionized water; samples were
stored for posterior use.
2.4. Synthesis of Iron Oxide Folate Fluorescent Nanoparticles
(FA-IONPs-RITC). To create the multifunctional system,
∼1.3mg of RITC (0.25mM)was dissolved in 10mL of DMSO.
Then, the solution was added dropwise in the dark to the
previous iron oxide folate suspension (IONPs-FA). The
resulting suspension was sonicated during an hour. After
that, the systemwas thoroughly washed with deionized water
viamagnetic concentration and stored for posterior use (see
Figure 1(c)).
2.4.1. Size and Morphology. Nanoparticles were analyzed by
TEM in a JEOL JEM 2010 HT microscope operating at
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Figure 1: Schematic synthesis of amine-functionalized magnetite nanoparticles: (a) the surface of IONPs was modified with 2-AEP to form
an amine-functionalized phosphonate monolayer, and (b) folic acid/rhodamine isothiocyanate were conjugated through the carbodiimide
reaction, in order to obtain FA-IONPs-RITC.
200 kV in order to observe the two-dimensional relative size
and morphology of nanoparticles. Samples were prepared
for analysis by evaporating a drop of aqueous product on a
carbon-coated TEM copper grid. At least 1000 nanoparticles
were measured using the Image J software, to determine the
mean diameter of nanoparticles.
2.4.2. X-Ray Diffraction. X-ray diffraction (XRD) patterns of
naked iron oxide cores were recorded on a powder diffrac-
tometer Bruker D8 Advance to characterize the crystallite
type. Sample was concentered with magnetic decantation
and dried by evaporation at room temperature and high
vacuum. After that, sample was removed and desiccated
thoroughly over dried silica gel and posteriorly screened with
the goniometer at 2𝜃 angles from 5∘ to 80∘ at a step width of
0.03∘.
2.4.3. Infrared Spectroscopy. The IR spectra were acquired
from vacuum-dried samples on a PerkinElmer System 2000
spectrometer with an ATR platform (Pike Technologies) by
applying the Attenuated Total Reflection Fourier Transform
Infrared (ATR-FTIR) spectroscopy with a 4 cm−1 resolution,
40 scans, and operating range at 4000–40 cm−1.
2.4.4. UV-Vis Studies. The absorption spectra, in the range of
200–700 nm, were obtained through a Thermo Genesys 10S
spectrometer using a 1 cm quartz cuvette.
2.4.5. Fluorescence Spectroscopy. The emission fluorescence
spectra, in the range of 450–750 nm, were obtained through
a Horiba Jobin Yvon Spectrofluorometer (Fluoromax-P)
with dual excitation and emission monochromators in a
wavelength range between 350 and 800 nm. Nanoparticles
were measured with a 𝜆exc of 398 nm using a 1 cm cuvette.
Three-/0.5-second scans were acquired.
2.4.6. Determination of the Concentration of FA Conjugated
over the Surface of the IONPs. The number of FA molecules
attached per nanoparticle was calculated by UV-Vis spec-
troscopy using different FA concentration (2.5 to 10.0mM),
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as in the carbodiimide reaction described in the experimental
section.The concentration was calculated using the prepared
standard curve (𝑟2 = 0.9997, with excellent linearity from
0.0125mM to 15mM). The experiments were conducted in
triplicate.
2.4.7. Concentration of RITC Conjugated over the Surface of
the IONPs. Conjugation was determined by titration using
0.0125mM, 0.0375mM, and 0.0625mM RITC, employing
the synthesis method described in the experimental section.
Samples were washed with purified and deionized water,
and the corresponding nanoparticles were measured by
UV-Vis spectroscopy, calculating the concentration using the
prepared rhodamine isothiocyanate standard curve (𝑟2 ≥
0.9975, with excellent linearity from 0.0033mM to
0.0673mM). The experiments were conducted in triplicate.
2.4.8. Cell Proliferation Studies/Nanoparticle-Induced Cyto-
toxicity. HeLa (human cervix adenocarcinoma) cells (1 × 104
cells/well) were seeded onto a 96-well plate and cultured in
200𝜇L of folate-free RPMI medium containing 10% FBS,
100 unitsmL−1 penicillin, 100 𝜇gmL−1 streptomycin, and
0.25 𝜇gmL−1 amphotericin B at 37∘C in a humidified
5%-CO2/95%-air atmosphere and incubated for 24 h. The
cells were treated with 20𝜇L of different FA-IONPs-RITC
nanoparticle concentrations (0.5mgmL−1, 0.25mgmL−1,
0.125mgmL−1, and 0.0625mgmL−1) and 180 𝜇L of media
culture was added and incubated for 24 h at 37∘C in a
humidified incubator maintained at 5% CO2/95% air atmo-
sphere. Thereafter, cells were washed thoroughly with PBS to
remove the noninternalized nanoparticles. Cell viability was
evaluated using a crystal violet staining. Untreated cells
served as 100% viable cells.
2.4.9. Cellular Uptake. Nanoparticle uptake by HeLa cells
was evaluated using 5 × 105 cells/well seeded onto 24-well
plates and cultured in a total volume of 2000 𝜇L of folate-
free RPMImedium containing 10%FBS, 100 unitsmL−1 peni-
cillin, 10 𝜇gmL−1 streptomycin, and 0.25 𝜇gmL−1 ampho-
tericin B at 37∘C in a humidified 5%-CO2/95%-air atmo-
sphere at 37∘C in a humidified incubator maintained at
5%CO2/95% air atmosphere. To test nanoparticle uptake
via folate receptors, a group of HeLa cells were pretreated
with 500𝜇L of free folic acid (11mg/mL) in order to sat-
urate receptors and incubated at 37∘C for 2 h. After recep-
tor saturation, both blocked and nonblocked HeLa cells
were treated with 40 𝜇L of IONPs (at a concentration of
0.25mgmL−1) eluted in PBS for 3 h, posteriorly supernatants
were collected and measured by UV-Vis spectroscopy at
280 nm, and absorbances were extrapolated to FA calibra-
tion curve. Uptake percentage was calculated, using the
baseline as untreated cells in the same conditions. The
experiment was performed in triplicate. Finally the images
for the cellular uptake test were obtained with an inverted
confocal microscope, consisting of an Olympus IX80 with
a Plan-Neofluar 40x, AxioVert (Carl Zeiss) objective, and an
AxioVision software.
3. Results and Discussion
3.1. Size and Morphology. The coprecipitation method for
obtaining magnetic iron oxide nanoparticles is one of the
fastest and easiest methods for this purpose. Nanoparticles
were synthetized in a molar ratio of Fe3+ : Fe2+ of 2 : 1.
Transmission electron microscopy (TEM) studies of IONPs
revealed that the as-synthesized magnetite nanoparticles
were closer to a spherical form and were uniform and
homogeneous, which corresponds to that previously reported
[26, 27].
The IONPs were obtained with a mean hydrodynamic
diameter of 18.65 nm ± 0.17 nm (Figure 2(a)). Size distri-
bution showed a monomodal population; the frequency
histogram is shown in Figure 2(b). The EDS patterns shown
in (Figure 2(c)), diffraction from the samples consisting
of fine particles, and the broad ring patterns from crystal
planes attributed to Fe3O4 nanoparticles confirm the nucleus
composition. Additionally, crystallographic High Resolution
TEM (HRTEM) showed the highly crystalline Fe3O4
nanoparticles with the lattice fringes, corresponding to (220)
and (111) planes of magnetite crystal with lattice spacing of
0.30 and 0.49 nm, respectively.
Evidence of identity and crystal structure was further
verified by X-ray diffraction patterns (Figure 3). Intensity
signals appeared at defined scattering angles 2𝜃 with the
most prominent ones at 18.26∘, 30.05∘, 35.54∘, 43.11∘, 53.42∘,
56.92∘, 62.63∘, and 73.97∘ (Figure 2).TheBragg peaks could be
assigned to specific diffraction planes inside the lattice: (111),
(220), (311), (400), (422), (511), (440), and (533) correspond-
ing to magnetite (Fe3O4), in agreement with JCPDS (16-
0629).
3.2. FT-IR Studies
3.2.1. Iron Oxide Nanoparticles. The Far-IR and FT-IR (Mid)
spectra of IONPs obtained showed the characteristic vibra-
tions for the iron oxide material, in its magnetite phase
(Figure 4(a)). For the first case (700–40 cm−1), the medium-
intense band at 345 cm−1 is attributed to the vibration of the
magnetite core. The previously mentioned band has been
previously reported to be specific for Fe3O4 [28]. In the
second case, for the medium zone (4500–400 cm−1), the
expected vibrational bands were observed at 558 cm−1 and
3256 cm−1. The first one corresponds to the specific Fe-O
vibration of iron oxide nanoparticles, which confirms the
material expected.The band at 3256 cm−1 was assigned to the
-OH st vibration groups due to adsorbed water on the surface
of the iron oxide nanoparticles [29, 30].
3.2.2. Amino-Modified Nanoparticles. The FT-IR of 2-AEP
functionalized IONPs (Figure 4(b)) showed a strong band
at 1026 cm−1 from the st vibration related to the overlapping
of the signals which correspond to the vibrations of M-O-P,
P=O, and the P-O bond. The band at 3361 cm−1 corresponds
to the -NH2 group st vibration, which is confirmed with the
bending scissoring vibration present at 1631 cm−1. These two
bands confirm the presence of the amino-terminal groups
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Figure 2: (a) TEM micrograph of unmodified magnetite nanoparticles; (b) particle size distribution (PSD) histogram and adjusted fit
function; (c) HRTEM of a fine particle and (d) DR pattern attributed to the diffraction from the crystal planes of Fe3O4 nanoparticles.
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Figure 3: XRD pattern of prepared magnetite (Fe3O4) nanopar-
ticles indicative of inverse spinel structure. Significant signals are
assignable to diffraction planes (111), (220), (311), (222), (400), (422),
(511), (440), and (533).
on the nanoparticle surface, which are necessary for the
posterior functionalization. The peak for the magnetite core
at 558 cm−1 shifts towards higher wavenumbers, to 570 cm−1.
Also, a significant decrease in the intensity of this band was
observed, which indicates the adsorption of phosphonic acids
onto the magnetite surface.
3.2.3. IONPs-FA System. In the FT-IR spectrum of folate-
conjugated nanoparticles (Figure 4(c)), the peak in the range
of 3100–3500 cm−1 was assigned to the N-H st vibration
from the -NH2 and amine NH groups from folic acid. At
1648 cm−1, the band present is related to the carbonyl group
st vibration from amide and acidic groups, which exhibits less
intensity and was shifted to ∼1700 cm−1, indicating that folic
acid was successfully attached to the IONPs. The bands at
1606 cm−1 and 1548 cm−1 were assigned to the characteristic
FA st vibrations (amide II and amide I, resp.), which indicate
the successful conjugation to the nanoparticle surface. The
presence of the new band at 1530 cm−1 was confirmed from
the st vibration of the amide binding between Fe3O4-NH2-
FA, which indicates the formation of an extra amide bond
attributed to the FA attachment onto the surface of IONPs,
as well as the amide bands within the FA structure. Finally, it
is important tomention that the vibration from themagnetite
6 Journal of Nanomaterials
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Figure 4: FT-IR spectra of (a) unmodified and amino-functionalized magnetite nanoparticles, (b) iron oxide folate conjugate nanoparticles,
and (c) unmodified magnetite nanoparticles in far infrared.
core still appears at 548 cm−1, which suggests that, even with
the formation of the conjugate, the core does not suffer any
important alteration [18].
3.3. UV-Vis Studies. TheUV-Vis spectra from the unmodified
magnetite, folic acid conjugate, rhodamine conjugate, folic
acid/rhodamine magnetite nanoparticles, folic acid solution,
and rhodamine solution have been depicted in the Fig-
ure 5(a). The magnetite core of the system, in the range
200–700 nm of the UV-Vis spectra, showed a characteristic
band around 360 nm which demonstrated a suitable synthe-
sis. The peak at ∼280 nm was assigned to FA due to the well-
known 𝜋-𝜋∗ transitions from the pteridine ring moiety in
the FA structure [31]. This UV-Vis band is present in the FA
aqueous solution at 282 nm and in the IONPs-FA system at
283 nm. In the case of the FA-IONPs-RITC system, in which
FA is also present, the band still appeared at 283 nm [29].
On the other hand, for the UV-Vis spectra for the same
systems but focus on the RITC molecules, a band around
550 nm is present, which has been reported in previous works
(536 nm for IONPs-RITC and 580 nm for FA-IONPs-RITC)
[32], and although it is broad, the maximum absorption
occurs in the same region.
3.4. Fluorescence Studies. In Figure 5(b), the fluorescence
emission spectra from magnetite, folic acid conjugate, rho-
damine conjugate, folic acid/rhodamine magnetite nanopar-
ticles, folic acid solution, and rhodamine solution have been
depicted.
The band around 575 nm for the fluorescent emission
spectra of the systems containing rhodamine (FA-IONPs-
RITC and IONPs-RITC) and the one for the solution of
RITC are in excellent agreement with the previously reported
around 570–575 nm [33, 34]. The differences in the band are
due to the chemical environment, and the low intensity is due
to the quantity employed in the synthesis procedure (being
less than 0.1% of the total system).
For the systems with FA, either FA-IONPs-RITC or
IONPs-AF, the emission spectra presented a common band
at 545 nm. In the case of FA-IONPs-RITC, a second band
appeared at 579 nm that corresponds to the RITC molecule
previously described. For the band at 545 nm, according to
previous studies, FA could be present in two forms (basic
and acid), due to the pteridine ring moiety. In the emission
spectra, the alkaline form used to have a band between 300
and 400 nm and another band in the 230–290 nm range with
higher absorption coefficients than their acid form. On the
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Figure 5: (a) UV-Vis spectra of unmodified magnetite, folic acid conjugate, rhodamine conjugate, folic acid/rhodamine magnetite
nanoparticles, folic acid solution, and rhodamine solution. (b) Fluorescence emission spectra of magnetite, folic acid conjugate, rhodamine
conjugate, folic acid/rhodamine magnetite nanoparticles, folic acid solution, and rhodamine solution.
Table 1: Determination of concentration of FA and RITC conjugated over the IONPs’ surface.
Initial [FA]
[mgmL−1]
% FA in IONPs’ surface
[%]
FA in IONPs’ surface
[mgmL−1]
Initial [RITC]
[mgmL−1]
% RITC in IONPs’
surface [%]
RITC in IONPs’ surface
[mgmL−1]
4.4 98.8 4.3 0.75 96.8 0.72
3.8 98.3 3.7 2.25 96.9 2.18
3.2 98.2 3.1 3.75 97.0 3.63
2.6 98.0 2.5
2.2 97.7 2.1
1.0 96.0 0.9
other hand, the complete molecule of FA usually presents
two bands (at 255 nm and 285 nm) in its alkaline form and
an overlapping of the same for the acid form, resulting in a
unique band at 285 nm.
Considering this and assuming that the system conjuga-
tionwas carried out according towhat is previously proposed,
it is possible to suggest that the pteridine moiety is exposed
on system surface. Thus, with the fluorescence studies, it was
possible to observe a relative increment of the band at 545 nm,
which corresponds to the alkaline form, indicating, in that
way, the correct and suitable system conjugation. However,
the magnetite core presented a lower intensity band in the
same region (∼545 nm), so it is possible to suggest that, in the
FA-IONPs-RITC and IONPs-RITC systems, a contribution
of both compounds (IONPs and FA) existed in order to
increase the intensity of the band in that wavelength. As for
the IONPs-RITC system, there was no FA (with its pteridine
ring moiety), which can cause the appearance of a band.
3.5. FA Conjugated over the IONPs’ Surface. In accordance
with the percentages obtained from analysis, it was possible
to observe that, even at the lowest initial concentration of
FA, 𝑎 > 95% of FA in IONPs surface was reached. Also was
important the fact that the reaction had amaximal saturation
point with 𝑎 concentration > 5.0mM, where the percentages
were over 98%.These data results were important to optimize
the quantities of FA in the final system. In Table 1, the concen-
trations of FA employed and the percentage of conjugation
over the nanoparticle surface are shown.
3.6. RITC Conjugated over the IONPs’ Surface. The results
demonstrate that, even at the lowest initial concentration of
RITC, 𝑎 > 95% was conjugated in IONPs surface. The sat-
uration of the system for this specific case was reached even
with the lowest initial concentration employed, where the
percentageswere over 96%.These data results were important
to optimize the quantities of RITC in the final system.
In Table 1, the RITC concentrations and the conjugation
percentage are shown.
Magnetite nanoparticles were successfully prepared in
accordance with previous reports using a chemical coprecipi-
tationmethod in a basicmedium, obtaining spheroidal forms
with nanometric size [26]. The amino-modified nanoparti-
cles were used as precursor, the functionalization was carried
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out using a derivative of phosphonic acid that undergoes easy
formation of a self-assembled, strongly organicmonolayer on
the nanoparticle surface, and established mechanisms are the
chemisorption of 2-AEP on INOPs for the introduction of
polar functional groups onto the surface [27]. This coating
allows further functionalization by chemical reactions [2].
Several studies have reported that phosphonates and phos-
phates bind efficiently to the iron oxide nanoparticle surface
and can be useful as potential alternatives to link fatty acids
or other functional groups. Also, they have good biocom-
patibility and a high capacity to form strong complexes
with transition metals in aqueous solution and show suitable
affinity for the metal oxide surface [2, 35]; additionally, a
significant increase on colloidal and chemical stability was
observed preventing nanoparticle oxidation processes.
Considering that colloidal stability in an aqueous and
physiological medium is one of the most important issues
related to the biomedical applications of nanoparticles,
these polar functional groups render nanoparticles ther-
modynamically stable against aggregation and keep them
well-dispersed in aqueous media. Furthermore, this system
facilitates conjugation with a variety of molecules through
sulfhydryl, carboxyl, anhydride, or imine groups, allowing
easy manipulation of the surface functionality [35].
The molecular imaging techniques provide a reliable
methodology to monitor and record the presence, location,
and extent of diseases, although methods such as computed
tomography and magnetic resonance imaging have been
primary tools for cancer diagnostic, the introduction of
new criteria and recommendations for the assessment of
an adequate diagnostic, and measure of progression disease,
promoting the development of bimodal targeted contrast
agents for the detection of molecular markers with both MRI
and fluorescence imaging.
In our case, the formation of magnetofluorescent
nanoparticles was achieved through a covalent immobili-
zation of rhodamine B isothiocyanate (RITC) on the particle
surface, bymeans of a thiourea linkage through a nucleophilic
addition of surface-pendent amine to isothiocyanate groups,
to which primary amino groups of suitable organicmolecules
can be covalently linked, forming the magnetic fluorescent
carrier, in this particular case [22, 36].
To achieve specificity and cell receptor selectivity, the
magnetite nanoparticles were functionalized with folic acid.
The active-NH2 groups present on the amino-functionalized
nanoparticle surface were covalently conjugated with FA via
activation of the carboxyl groups in its glutamic acid moiety
by the carbodiimide method. This method may lead to the
formation of two structural isomers, in which FA is linked
either through the 𝛼-carboxyl or through 𝛾-carboxyl group
of its glutamic acid moiety. However, the folate linked via 𝛾-
carboxyl group is formed as the major isomer because it is
more prone to this reaction due to its higher reactivity and
retains a strong affinity towards its receptor, whereas its 𝛼-
carboxyl derivatives are not recognized as readily [36].
The information obtained with analytical technique sug-
gests that the conjugation of the FA at the surface of the
IONPs was carried out successfully, as well as the preparation
of the multifunctional system FA-IONPs-RITC.
3.7. Nanoparticle-Induced Cytotoxicity. For the cell viability
test, the IONPs exposure time was 24 h as usual. It is
important to note that the highest IONPs concentration
employed (0.5mgmL−1) was lower than concentrations used
in other studies with different cell lines but much higher
than inmany other works with that employedmagnetite [37].
According to the results shown in Figure 6(a), there was a sig-
nificant difference between the lowest (0.0mgmL−1) and the
highest (0.5mgmL−1) concentrations. Despite this, all treat-
ments showed cell viability higher than 80%. The highest
FA-IONPs-RITC concentration (0.5mgmL−1) showed 82.5%
of viability, which demonstrated the biocompatibility of the
multifunctional system.
3.8. Cellular Uptake. The folate-conjugated nanoparticles
were found to be distributed within the cytoplasm, sug-
gesting cellular internalization through receptor-mediated
endocytosis, instead of adhesion to the cell surface. This
study unequivocally establishes that all the iron oxide folate
nanoconjugates, developed in the course of this research, are
preferentially targeted towards cancer cells and effectively
internalized (63 ± 7% of internalization with respect to
43 ± 5% of the blocked group). Also, the results indicated
that the system with FA could enhance the intracellular
uptake of the IONPs effectively, assuming that FA works as
a tumor-targeting ligand, which likely enhances receptor-
mediated endocytosis [31]. Receptor-mediated internaliza-
tion of nanoparticles by FA receptor in overexpressing
cancer cells was further demonstrated using an inverted
confocalmicroscope (Olympus IX80). As was predicted from
the cytotoxicity experiments, photomicrographs (taken with
an Olympus IX80 inverted confocal microscope and an
AxioVision software) clearly showed that cellular structures
were well preserved without morphology abnormalities after
nanoparticles treatment (see Figure 6(b)).
According to previous reports, a nanoparticle size
between 10 and 100 nm results in systems with a size small
enough to avoid the mononuclear phagocyte system (MPS)
and to penetrate the capillary body cavities. Also, for medical
applications, nanoparticles must conform to a size smaller
than 100 nm, at which they possess unique physicochemical
and pharmacokinetic characteristics are desirables [12, 38].
Generally, once a tumor-targeting ligand conjugate has
reached its target receptor, uptake and internalization can
occur through receptor-mediated bioevents,mainly receptor-
mediated endocytosis, but phagocytosis and pinocytosis can
also contribute to internalization. After endocytosis, most
but not all ligand-receptor complexes dissociate in the endo-
somes and the ligand eventually ends up in the lysosomes,
while receptors are often recycled and transported back to the
cell surface by transport vesicles [31].
The results of the internalization of magnetic nanopar-
ticles are dependent on two factors: (I) the type of coating
and (II) the nanoparticle concentration [31]. In the system
designed, FA demonstrated that it can promote tumor cell
receptor-mediated internalization [17].
A promising diagnostic imaging methods consist in
molecular targeting with exogenous fluorescent agents,
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Figure 6: (a) Effect of folate-rhodamine-conjugated nanoparticles on the HeLa cells viability. Cells incubated with different nanoparticle
concentrations for 24 h at 37∘C followed by crystal violet staining. ∗No significant reduction (𝑝 < 0.05) in cellular viability was observed, the
survival rate being higher than 80%, even at the highest nanoparticle concentration. (b) Photomicrographs of cellular uptake test in HeLa
cells at two different concentrations. The black arrows show the internalization of the system, which is visible even at low concentrations
(0.065mgmL−1).
employing sensitive targets to report disease and metabolism
activity; FA-IONPs-RITC system provides a new class of
magnetic/fluorescent nanomaterial. Additionally, fluorescent
properties of this conjugate, water soluble, chemically stable,
and biocompatible, are desirable features for pharmaceutical
purposes.Newmolecular imaging devices offer the advantage
for better spatial resolution and could be applied to extend
three-dimensional tissue architecture and dynamicmetabolic
processes. The development of hybrid contrast agents is
based on increasing capabilities to overcome depth tissue
limitations and spatial accuracy by image fusion techniques.
4. Conclusions
In this work, iron oxide magnetite nanoparticles, modified
with folic acid/rhodamine, were successfully synthetized via
carbodiimide reaction. This system demonstrated optimal
conditions for their use in medical application.The proposed
uptakemechanism is through folic acid receptor endocytosis.
However, to assure that such mechanism is involved, it
is necessary to carry out studies focused on the labeling
and tracing of the mechanism through recognition of its
receptor. Also, PK studies are crucial in order to elucidate
their behavior in vivo and also to prove their magnetic and
fluorescent properties.
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